In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
In this podcast, Anne Teitelman, PhD, discusses how the human papillomavirus vaccination rate among adolescents falls short of national goals, as well as her and her colleagues intention to promote this...
In this podcast, Anne Teitelman, PhD, discusses how the human papillomavirus vaccination rate among adolescents falls short of national goals, as well as her and her colleagues intention to promote this...
In this commentary, Michael B. Grosso, MD, writes about the history of vaccine hesitancy, how hesitancy has affected the use of the human papillomavirus vaccine, and what you can do to reduce hesitancy in...
In this commentary, Michael B. Grosso, MD, writes about the history of vaccine hesitancy, how hesitancy has affected the use of the human papillomavirus vaccine, and what you can do to reduce hesitancy in...
In this Pediatrics Top Paper, Jessica Tomaszewski, MD, writes about a new review of HPV prevalence data in the United States that compares the pre-vaccine era to the post-vaccine era.
In this month’s Pediatrics Top Paper, Dr Jessica Tomaszewski writes about a new review of HPV prevalence data in the United States that compares the pre-vaccine era to the post-vaccine era.
